Randomised Controlled Trial of Melatonin for Delayed Sleep Phase Disorder

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Delayed Sleep Phase Disorder (DSPD) is a sleep disorder affecting 7-16% of adolescents and young adults. It is associated with poor health and impaired academic and social functioning. We will test in a randomised controlled trial whether the hormone melatonin can be used as a treatment for DSPD. We will also assess whether genetic factors are linked to treatment outcome. The study will provide a much-needed standardised diagnostic and treatment approach for DSPD.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $711,136.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

circadian rhythms | clinical trial | melatonin | sleep | sleep disorders | sleep disturbance | sleep onset insomnia | sleepiness